X-100633518-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_003270.4(TSPAN6):c.472G>A(p.Asp158Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000584 in 1,198,730 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_003270.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPAN6 | NM_003270.4 | c.472G>A | p.Asp158Asn | missense_variant | 5/8 | ENST00000373020.9 | NP_003261.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPAN6 | ENST00000373020.9 | c.472G>A | p.Asp158Asn | missense_variant | 5/8 | 1 | NM_003270.4 | ENSP00000362111 | P1 | |
TSPAN6 | ENST00000612152.4 | c.208G>A | p.Asp70Asn | missense_variant | 5/7 | 5 | ENSP00000482130 | |||
TSPAN6 | ENST00000494424.1 | n.744G>A | non_coding_transcript_exon_variant | 6/6 | 2 | |||||
TSPAN6 | ENST00000496771.5 | n.884G>A | non_coding_transcript_exon_variant | 5/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111273Hom.: 0 Cov.: 22 AF XY: 0.0000598 AC XY: 2AN XY: 33463
GnomAD4 exome AF: 0.00000460 AC: 5AN: 1087457Hom.: 0 Cov.: 29 AF XY: 0.00000564 AC XY: 2AN XY: 354745
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111273Hom.: 0 Cov.: 22 AF XY: 0.0000598 AC XY: 2AN XY: 33463
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at